HUNTERIAN MEDICINE LLC
BALTIMORE, MD · Founded 2016 · CIK 0001685325 · Biotech · Private
AAV-delivered CRISPR gene therapy targeting HIF-2α for pulmonary arterial hypertension
hunterian.com →- Grants
- $670K
- 2 awards
- Sector median: 1
- Raised
- $230K
- 1 Form D · Sep 2016
- 121 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 14
- 0 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $230,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Gene Therapy for Cystic Fibrosis Using Novel Compact Promoters | $320,000 | |
| Federal grant | Department of Health and Human Services · Phase I · An early-intervention gene-editing therapeutic for Pulmonary Arterial Hypertension | $350,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2624 | Dome Therapeutics, LLC | — | $250K |
| 2625 | X1 Biotech Inc. | — | $235K |
| 2626 | ZYMTRONIX CATALYTIC SYSTEMS, INC. | — | — |
| 2627 | HUNTERIAN MEDICINE LLC | — | $230K |
| 2628 | Daya CNS, LLC | — | $228K |
| 2629 | Zepteon, Inc | — | $210K |
| 2630 | VERRA THERAPEUTICS LLC | — | $205K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Vinod Jaskula-RangaDirector · Executive Officer
- Vinod RanganathanDirector · Executive Officer
- James SilvergladPromoter
Patents
- Compact Promoters For Gene Editingapplication
- Compact Promoters For Gene Expressionapplication
- Compositions And Methods Of Use Thereof For The Treatment Of Duchenne Muscular Dystrophyapplication
- Compositions And Methods Of Use Thereof For The Treatment Of Duchenne Muscular Dystrophyapplication
- Compact Bidirectional Promoters For Gene Expressionapplication
- Compact Promoters For Gene Editingapplication
- Compact Promoters For Gene Expressionapplication
- Compact Promoters For Gene Editingapplication
- Compact Promoters For Gene Expressionapplication
- Compositions And Methods Of Use Thereof For The Treatment Of Duchenne Muscular Dystrophyapplication
- Compositions and Methods of Use Thereof for the Treatment of Duchenne Muscular Dystrophyapplication
- Compact Bidirectional Promoters For Gene Expressionapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.